China Universal Asset Management Company’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

China Universal Asset Management Company’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,331	Closed	-$1.92K	–	491
2023 Q3	$1.92K	Buy	1,331 +654	+97%	+$1.27K	﹤0.01%	434
2023 Q2	$1.69K	Sell	677 -9	-1%	-$25	﹤0.01%	436
2023 Q1	$1.84K	Buy	686 +172	+33%	+$826	﹤0.01%	433
2022 Q4	$2.79K	Buy	514 +113	+28%	+$947	﹤0.01%	350
2022 Q3	$5K	Buy	+401	New	+$4.58K	﹤0.01%	280

Other funds holding GTHX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

China Universal Asset Management Company's GTHX Position: Q4 2023 in Review

China Universal Asset Management Company sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2023, closing a stake of 1,331 shares — an estimated $1.92K sold.

China Universal Asset Management Company first reported a position in GTHX in Q3 2022 and held it in 5 quarters. The position peaked at $5K in Q3 2022. 87 funds tracked by Wall St. Rank hold GTHX as of Q4 2023.

China Universal Asset Management Company reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
China Universal Asset Management Company sold 1,331 G1 Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $1.92K.
China Universal Asset Management Company first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2022 and held it in 5 quarters.
China Universal Asset Management Company's G1 Therapeutics, Inc. Common Stock position peaked at $5K in Q3 2022.
87 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.